Literature DB >> 15349823

The chemokine network in cancer--much more than directing cell movement.

Hagen Kulbe1, Neil R Levinson, Fran Balkwill, Julia L Wilson.   

Abstract

Cytokine and chemokine gradients are central to the directed movement of cells in both homeostatic and pathological processes. Most cancers have a complex chemokine network which can influence immune responses to the tumor, direct the extent and cellular composition of the leukocyte infiltrate and also play a role in angiogenesis. Tumor cells can also hijack the chemokine system and gain expression of certain chemokine receptors and respond to specific chemokine gradients. Chemokine receptor expression and activation on malignant cells may be central to the growth, survival and migration of cancer cells from the primary tumor. Chemokine receptors, both CC and CXC have been detected on malignant cells and the relevant ligands are sometimes expressed at the tumor site and at sites of tumor spread, suggesting a role for the chemokine family in malignant growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349823     DOI: 10.1387/ijdb.041814hk

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  58 in total

1.  Identification and chromosomal localizations of signal transduction genes associated with human ovarian cancer metastasis.

Authors:  Zhu Xin; Xu Shenhua; Mou Hanzhou; Gu Linhui; Zhu Chihong; Liu Xianglin
Journal:  Med Oncol       Date:  2012-02-05       Impact factor: 3.064

2.  CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.

Authors:  Hsiu-Ting Tsai; Shun-Fa Yang; Dar-Ren Chen; Szu-Erh Chan
Journal:  Med Oncol       Date:  2012-02-29       Impact factor: 3.064

3.  CXCL12, CXCR4 and IFNγ genes expression: implications for proinflammatory microenvironment of breast cancer.

Authors:  Karen Brajão de Oliveira; Roberta Losi Guembarovski; Alda Maria Fiorina Losi Guembarovski; Ana Cristina da Silva do Amaral Herrera; Walter Jorge Sobrinho; Carolina Batista Ariza; Maria Angelica Ehara Watanabe
Journal:  Clin Exp Med       Date:  2012-06-15       Impact factor: 3.984

Review 4.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 5.  Crossing the endothelial barrier during metastasis.

Authors:  Nicolas Reymond; Bárbara Borda d'Água; Anne J Ridley
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

6.  Gβ1 controls collective cell migration by regulating the protrusive activity of leader cells in the posterior lateral line primordium.

Authors:  Hui Xu; Ding Ye; Martine Behra; Shawn Burgess; Songhai Chen; Fang Lin
Journal:  Dev Biol       Date:  2013-11-04       Impact factor: 3.582

Review 7.  Multimodality imaging of CXCR4 in cancer: current status towards clinical translation.

Authors:  T R Nayak; H Hong; Y Zhang; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

8.  Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.

Authors:  Xiao-Hua Zeng; Zhou-Luo Ou; Ke-Da Yu; Lan-Yun Feng; Wen-Jing Yin; Jing Li; Zhen-Zhou Shen; Zhi-Min Shao
Journal:  Med Oncol       Date:  2014-08-06       Impact factor: 3.064

Review 9.  Deconvoluting the obesity and breast cancer link: secretome, soil and seed interactions.

Authors:  Nikki A Ford; Kaylyn L Devlin; Laura M Lashinger; Stephen D Hursting
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-04       Impact factor: 2.673

10.  Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1.

Authors:  Anne-Christine Hick; Jonathan M van Eyll; Sabine Cordi; Céline Forez; Lara Passante; Hiroshi Kohara; Takashi Nagasawa; Pierre Vanderhaeghen; Pierre J Courtoy; Guy G Rousseau; Frédéric P Lemaigre; Christophe E Pierreux
Journal:  BMC Dev Biol       Date:  2009-12-14       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.